10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELEVANCE HEALTH, INC. | |||
Ticker: ELV Fiscal Year: 2011 | |||
Consolidated Statements Of Income | |||
Period Ending Dec 31, 2011 10-K (Filed: Feb 22, 2012) | |||
| (In Thousands, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | |
| Revenues | |||
| Premiums | $ 55,969,600 | 53,973,600 | 56,382,000 |
| Administrative fees | 3,854,600 | 3,730,400 | 3,751,700 |
| Other revenue | 41,000 | 36,500 | 606,300 |
| Total operating revenue | 59,865,200 | 57,740,500 | 60,740,000 |
| Net investment income | 703,700 | 803,300 | 801,000 |
| Gain on sale of business | 3,792,300 | ||
| Net realized gains on investments | 235,100 | 194,100 | 56,400 |
| Other-than-temporary impairment losses on investments: | |||
| Total other-than-temporary impairment losses on investments | (114,700) | (70,800) | (538,400) |
| Portion of other-than-temporary impairment losses recognized in other comprehensive income | 21,400 | 31,400 | 88,200 |
| Other-than-temporary impairment losses recognized in income | (93,300) | (39,400) | (450,200) |
| Total revenues | 60,710,700 | 58,698,500 | 64,939,500 |
| Expenses | |||
| Benefit expense | 47,647,500 | 44,930,400 | 47,122,300 |
| Selling, general and administrative expense: | |||
| Selling expense | 1,616,800 | 1,610,300 | 1,685,500 |
| General and administrative expense | 6,818,800 | 7,122,300 | 7,333,800 |
| Total selling, general and administrative expense | 8,435,600 | 8,732,600 | 9,019,300 |
| Cost of drugs | 419,000 | ||
| Interest expense | 430,300 | 418,900 | 447,400 |
| Amortization of other intangible assets | 239,400 | 241,700 | 266,000 |
| Impairment of other intangible assets | 21,100 | 262,500 | |
| Total expenses | 56,752,800 | 54,344,700 | 57,536,500 |
| Income before income tax expense | 3,957,900 | 4,353,800 | 7,403,000 |
| Income tax expense | 1,311,200 | 1,466,700 | 2,657,100 |
| Net income | 2,646,700 | 2,887,100 | 4,745,900 |
| Net income per share | |||
| Basic | 7.35 | 7.03 | 9.96 |
| Diluted | 7.25 | 6.94 | 9.88 |
| Dividends per share | 1.00 | ||
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELEVANCE HEALTH, INC. | |||
Ticker: ELV Fiscal Year: 2011 | |||
Consolidated Statements Of Cash Flows | |||
Period Ending Dec 31, 2011 10-K (Filed: Feb 22, 2012) | |||
| (In Thousands, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | |
| Operating activities | |||
| Net income | $ 2,646,700 | 2,887,100 | 4,745,900 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Net realized gains/losses on investments | (235,100) | (194,100) | (56,400) |
| Other-than-temporary impairment losses recognized in income | 93,300 | 39,400 | 450,200 |
| Loss on disposal of assets | 3,300 | 1,900 | 16,400 |
| Gain on sale of business | (3,792,300) | ||
| Deferred income taxes | 74,300 | 101,800 | 61,300 |
| Amortization, net of accretion | 541,500 | 497,700 | 446,400 |
| Impairment of goodwill and other intangible assets | 21,100 | 262,500 | |
| Depreciation expense | 95,700 | 103,100 | 107,100 |
| Impairment of property and equipment | 95,300 | ||
| Share-based compensation | 134,800 | 136,000 | 153,600 |
| Excess tax benefits from share-based compensation | (42,200) | (28,100) | (9,600) |
| Changes in operating assets and liabilities, net of effect of business combinations: | |||
| Receivables, net | (401,800) | 109,700 | (484,200) |
| Other invested assets | (8,900) | 5,100 | (62,500) |
| Other assets | (259,200) | (320,100) | (119,300) |
| Policy liabilities | 978,000 | (330,700) | (748,200) |
| Unearned income | 35,100 | (158,600) | (27,300) |
| Accounts payable and accrued expenses | (208,700) | (58,200) | 952,800 |
| Other liabilities | (13,600) | (208,400) | (248,800) |
| Income taxes | (44,600) | (1,239,800) | 1,391,400 |
| Other, net | (14,200) | (43,500) | (100) |
| Net cash provided by operating activities | 3,374,400 | 1,416,700 | 3,038,900 |
| Investing activities | |||
| Purchases of fixed maturity securities | (11,914,800) | (10,567,200) | (7,186,800) |
| Proceeds from fixed maturity securities: | |||
| Sales | 10,446,200 | 7,215,100 | 4,096,600 |
| Maturities, calls and redemptions | 1,891,300 | 3,321,700 | 1,551,700 |
| Purchases of equity securities | (355,600) | (350,900) | (318,900) |
| Proceeds from sales of equity securities | 287,400 | 197,900 | 577,300 |
| Purchases of other invested assets | (207,900) | (91,400) | (49,000) |
| Proceeds from sales of other invested assets | 29,400 | 34,500 | 3,500 |
| Changes in securities lending collateral | 28,900 | (504,800) | 132,400 |
| Purchases of subsidiaries, net of cash acquired | (600,000) | (300) | (66,300) |
| Proceeds from sales of subsidiaries, net of cash sold | 4,672,300 | ||
| Purchases of property and equipment | (519,500) | (451,400) | (378,400) |
| Proceeds from sales of property and equipment | 3,700 | 800 | 400 |
| Other, net | (31,100) | (75,500) | (32,000) |
| Net cash (used in) provided by investing activities | (942,000) | (1,271,500) | 3,002,800 |
| Financing activities | |||
| Net proceeds from (repayments of) commercial paper borrowings | 463,600 | (164,400) | (397,000) |
| Proceeds from long-term borrowings | 1,097,400 | 1,088,500 | 990,300 |
| Repayments of long-term borrowings | (705,100) | (481,700) | (919,300) |
| Proceeds from short-term borrowings | 100,000 | 100,000 | |
| Repayments of short-term borrowings | (100,000) | (98,000) | |
| Changes in securities lending payable | (29,000) | 504,900 | (132,400) |
| Changes in bank overdrafts | 264,300 | (28,000) | (344,100) |
| Repurchase and retirement of common stock | (3,039,800) | (4,360,300) | (2,638,400) |
| Cash dividends | (357,800) | ||
| Proceeds from issuance of common stock under employee stock plans | 245,000 | 143,600 | 126,500 |
| Excess tax benefits from share-based compensation | 42,200 | 28,100 | 9,600 |
| Net cash used in financing activities | (2,019,200) | (3,169,300) | (3,402,800) |
| Effect of foreign exchange rates on cash and cash equivalents | (400) | (3,200) | (6,700) |
| Change in cash and cash equivalents | 412,800 | (3,027,300) | 2,632,200 |
| Cash and cash equivalents at beginning of year | 1,788,800 | 4,816,100 | |
| Cash and cash equivalents at end of year | 2,201,600 | 1,788,800 | 4,816,100 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
ELEVANCE HEALTH, INC. | ||
Ticker: ELV Fiscal Year: 2011 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2011 10-K (Filed: Feb 22, 2012) | ||
| (In Thousands, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2011 | Dec 31, 2010 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $ 2,201,600 | 1,788,800 |
| Investments available-for-sale, at fair value: | ||
| Fixed maturity securities (amortized cost of $15,233.6 and $15,545.4) | 15,913,100 | 16,069,500 |
| Equity securities (cost of $937.7 and $861.4) | 1,188,100 | 1,236,200 |
| Other invested assets, current | 14,800 | 21,100 |
| Accrued investment income | 172,000 | 177,400 |
| Premium and self-funded receivables | 3,402,900 | 3,041,600 |
| Other receivables | 943,900 | 878,600 |
| Income taxes receivable | 105,800 | 32,300 |
| Securities lending collateral | 871,400 | 900,300 |
| Deferred tax assets, net | 424,800 | 460,900 |
| Other current assets | 1,859,000 | 1,534,100 |
| Total current assets | 27,097,400 | 26,140,800 |
| Long-term investments available-for-sale, at fair value: | ||
| Fixed maturity securities (amortized cost of $240.8 and $215.8) | 246,800 | 221,800 |
| Equity securities (cost of $28.4 and $32.8) | 28,800 | 33,400 |
| Other invested assets, long-term | 1,003,700 | 865,400 |
| Property and equipment, net | 1,418,100 | 1,155,500 |
| Goodwill | 13,858,700 | 13,264,900 |
| Other intangible assets | 7,931,700 | 7,996,800 |
| Other noncurrent assets | 433,600 | 488,300 |
| Total assets | 52,018,800 | 50,166,900 |
| Liabilities and shareholders' equity | ||
| Medical claims payable | 5,489,000 | 4,852,400 |
| Reserves for future policy benefits | 55,100 | 56,400 |
| Other policyholder liabilities | 2,278,200 | 1,909,100 |
| Total policy liabilities | 7,822,300 | 6,817,900 |
| Unearned income | 926,500 | 891,400 |
| Accounts payable and accrued expenses | 3,124,100 | 2,942,200 |
| Security trades pending payable | 51,700 | 33,300 |
| Securities lending payable | 872,500 | 901,500 |
| Short-term borrowings | 100,000 | 100,000 |
| Current portion of long-term debt | 1,274,500 | 705,900 |
| Other current liabilities | 1,654,100 | 1,617,300 |
| Total current liabilities | 15,825,700 | 14,009,500 |
| Long-term debt, less current portion | 8,420,900 | 8,147,800 |
| Reserves for future policy benefits, noncurrent | 730,700 | 646,700 |
| Deferred tax liabilities, net | 2,724,000 | 2,586,900 |
| Other noncurrent liabilities | 1,029,300 | 963,400 |
| Total liabilities | 28,730,600 | 26,354,300 |
| Commitments and contingencies-Note 14 | ||
| Shareholders' equity | ||
| Preferred stock, without par value, shares authorized-100,000,000; shares issued and outstanding-none | ||
| Common stock, par value $0.01, shares authorized-900,000,000; shares issued and outstanding: 339,372,680 and 377,736,929 | 3,400 | 3,800 |
| Additional paid-in capital | 11,679,200 | 12,862,600 |
| Retained earnings | 11,490,700 | 10,721,600 |
| Accumulated other comprehensive income | 114,900 | 224,600 |
| Total shareholders' equity | 23,288,200 | 23,812,600 |
| Total liabilities and shareholders' equity | 52,018,800 | 50,166,900 |
| External Links | |
| ELEVANCE HEALTH, INC. (ELV) Fiscal Year 2011 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |